5 Best Stocks to Buy According to Billionaire Dan Loeb

2. Danaher Corporation (NYSE:DHR)

Third Point Stake: $583,096,000

Percentage of Third Point’s Portfolio: 13.8%

Number of Hedge Fund Holders: 82

Danaher Corporation (NYSE:DHR) designs and markets products in the pharmaceutical and industrial sectors. The fund decreased its stake in the company by 8% during the previous quarter. Third Point Stake in Danaher Corporation (NYSE:DHR) amounts to a value of approximately $583 million.

On October 10, 2022, Luke Sergott, an analyst at Barclays, reduced his price target for Danaher Corporation (NYSE:DHR) to $305 while keeping an Overweight rating on the shares. The analyst believes that the life-sciences group can see a decline as risks related to foreign exchange still remain.

Weitz Investment Management mentioned Danaher Corporation (NYSE:DHR) in its Q2 2022 investor letter. Here is what the firm has to say:

Consistent with that approach, portfolio activity among our long holdings tilted toward purchases. We added to almost half our holdings by varying degrees, and we were pleased to initiate new positions in Danaher (NYSE:DHR). Danaher is a provider of instruments and diagnostic tools to medical, life science, and other desirable end-markets worldwide. The business generate significant free cash flow, possess strong competitive positions, and have excellent management teams with demonstrated acquisition records.

At the end of quarter ending June 2022, Fisher Asset Management was the most bullish on Danaher Corporation (NYSE:DHR), with a holding of 3,839,035 shares. As per Insider’s Monkey database, 82 hedge funds owned stakes in Danaher Corporation (NYSE:DHR) at the end of Q2 2022.